No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
H.C. Wainwright Maintains Edesa Biotech(EDSA.US) With Buy Rating, Maintains Target Price $21
Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Perspective Therapeutics (CATX) and Edesa Biotech (EDSA)
HC Wainwright & Co. Reiterates Buy on Edesa Biotech, Maintains $21 Price Target
Edesa Biotech Analyst Ratings
Edesa Biotech Files to Sell 7.81M Common Shares for Holders
Watching Edesa Biotech; Zacks Small-Cap Research Gives Stock $17 Price Valuation